NCT06622317 Abdominal Aortic Junction Tourniquet (AAJT-S) for Non-compressible Torso Haemorrhage
| NCT ID | NCT06622317 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Exanguination |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-09-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2024-11-01 with a primary completion date of 2026-09-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to evaluate the feasibility of a Abdominal Aortic Balloon Occlusion of the Aorta (AAJT-S) in exanguinating trauma patients with non-compressible truncal haemorrhage in the emergency room and the pre-hospital setting.
Eligibility Criteria
Inclusion Criteria: * aged, or believed to be aged, 18 years or above, * confirmed or suspected life-threatening lower body trauma (i.e. signs of inadequate perfusion of tissues, tachycardia, hypotension, suspected blood loss) * is thought to benefit from trauma resuscitation with AAJT-S or REBOA zone III Exclusion Criteria: * suspected additional bleeding source proximal to the umbilicus, or * known or suspected pregnancy at presentation, or * known abdominal aortic aneurysm
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06622317 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Exanguination. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06622317 currently recruiting?
Yes, NCT06622317 is actively recruiting participants. Contact the research team at gabriel.honnef@medunigraz.at for enrollment information.
Where is the NCT06622317 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT06622317 clinical trial?
NCT06622317 is sponsored by Medical University of Graz. The trial plans to enroll 10 participants.